Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients

Exp Dermatol. 2005 Jan;14(1):17-25. doi: 10.1111/j.0906-6705.2005.00241.x.

Abstract

Decreased production of T helper type 1 (Th1) cytokines, such as interferon-gamma (IFN-gamma) or interleukin-2 (IL-2), is a hallmark of atopic diseases. While accessory signals from antigen-presenting cells may be missing, T cells themselves may be suppressed in their ability to produce substantial amounts of Th1 cytokines. We show, in this study, that T cell receptor (TCR)-activated T cells from atopic dermatitis (AD) patients proliferate less than control T cells and produce lower amounts of IFN-gamma and IL-2, but comparable amounts of IL-4. Because mice lacking the nuclear factor kappa B (NF-kappaB) transcription factors - p65 or c-Rel - show reduced Th1, but undisturbed Th2 responses, we investigated the role of c-Rel and p65 for Th1 cytokine production in T cells from healthy and severe AD patients. TCR-activated primary T cells from healthy donors treated with c-Rel antisense oligonucleotides produced lower levels of IL-2 and IFN-gamma and proliferated less efficiently than the corresponding control T cells. Moreover, transfection of primary T cells with c-Rel or p65 enhanced proliferation and production of IL-2 and IFN-gamma. Nuclear extracts of activated primary T cells from AD donors bound weakly to NF-kappaB-specific oligonucleotides, compared to extracts from healthy control T cells. Western blotting studies revealed that nuclear, but not cytosolic, extracts from T cells of AD patients lacked significant amounts of c-Rel and p65. T cell clones derived from AD patients failed to sufficiently translocate c-Rel and p65 into the nucleus following activation. Thus, impaired nuclear translocation of c-Rel and p65 may determine an impaired Th1 cytokine response in AD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus / immunology
  • Adult
  • Antibodies, Monoclonal / pharmacology
  • CD28 Antigens / immunology
  • CD3 Complex / immunology
  • Cell Nucleus / immunology
  • Cell Nucleus / metabolism
  • Cell Proliferation
  • Cytokines / metabolism*
  • DNA / metabolism
  • Dermatitis, Atopic / blood
  • Dermatitis, Atopic / immunology*
  • Humans
  • Interferon-gamma / metabolism
  • Interleukin-2 / metabolism
  • Lymphocyte Activation / immunology
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Protein Binding
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-rel / genetics
  • Proto-Oncogene Proteins c-rel / metabolism*
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / metabolism
  • Th1 Cells / metabolism*
  • Transcription Factor RelA
  • Transcription Factor RelB
  • Transcription Factors / metabolism

Substances

  • Antibodies, Monoclonal
  • CD28 Antigens
  • CD3 Complex
  • Cytokines
  • Interleukin-2
  • NF-kappa B
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-rel
  • RELB protein, human
  • Transcription Factor RelA
  • Transcription Factors
  • Transcription Factor RelB
  • Interferon-gamma
  • DNA